Inotiv Inc
NOTV
Market Cap$58.4M
Close$
$-1.87
202.7% downside
Current Fair Value
202.7% downsideOvervalued by 202.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $58.40 Million |
|---|---|
| Enterprise Value | $87.45 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-4.19 |
| Beta | 4.1 |
| Outstanding Shares | 33,995,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.66 |
|---|---|
| PEG | 0.96 |
| Price to Sales | 0.13 |
| Price to Book Ratio | 0.46 |
| Enterprise Value to Revenue | 0.18 |
| Enterprise Value to EBIT | -1.16 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.55 |
| Debt to Equity | 0.31 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Inotiv Inc
409 employees
CEO: Jacqueline Lemke Bioanalytical Systems, Inc., operating as Inotiv, is a pharmaceutical development company providing contract research services and monitoring instruments to emerging pharmaceutical companies and the world's leading drug development compa...